(George Washington University) A team at the George Washington University Cancer Center received more than $1.8 million from the National Institutes of Health to develop genetically engineered models to comprehensively study the role of COMPASS, a protein complex that epigenetically regulates cell fate decisions that drive the initiation and progression of pancreatic cancer.
from EurekAlert! - Social and Behavioral Science https://ift.tt/2P1fEcb
No comments:
Post a Comment